Direct Answer
Abbott Laboratories reports revenue across 4 business segments in its fiscal 2025 Form 10-K. Medical Devices is the largest, with $21.4 billion of revenue (48% of the total), followed by Diagnostic Products at $8.9 billion (20%). 39% of revenue came from the United States.
How Does Abbott Laboratories Make Money?
No single line supplies a majority of revenue: the largest, Medical Devices, is 48%, which spreads Abbott Laboratories's exposure across several demand drivers. Between fiscal 2024 and 2025, Medical Devices grew fastest (+12.6%) and Diagnostic Products slowest (-4.3%), so the revenue mix tilts toward Medical Devices while that gap lasts.
| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| Medical Devices | $21.4 billion | $19.0 billion | 48.2% | 12.6% |
| Diagnostic Products | $8.9 billion | $9.3 billion | 20.2% | -4.3% |
| Nutritional Products | $8.5 billion | $8.4 billion | 19.1% | 0.5% |
| Established Pharmaceutical Products | $5.5 billion | $5.2 billion | 12.5% | 6.6% |
Which Abbott Laboratories Segments Earn the Most?
| Segment | FY2025 segment operating income | Segment margin |
|---|---|---|
| Medical Devices | $7.2 billion | 33.7% |
| Diagnostic Products | $1.7 billion | 19.5% |
| Nutritional Products | $1.6 billion | 18.4% |
| Established Pharmaceutical Products | $1.3 billion | 23.3% |
Segment operating income is the profit measure Abbott Laboratories reports to its chief operating decision maker for each segment. It usually leaves out corporate costs that are not allocated to a segment, so the segments usually add up to more than consolidated operating income, and margins are comparable within Abbott Laboratories more safely than against another company.
Where Does Abbott Laboratories's Revenue Come From?
Regions follow the definitions in the filing; most companies assign revenue by customer location.
| Region | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
|---|---|---|---|---|
| United States | $17.1 billion | $16.3 billion | 38.6% | 4.9% |
| All Other Countries | $16.0 billion | $14.8 billion | 36.0% | 8.1% |
| Germany | $2.8 billion | $2.5 billion | 6.2% | 8.7% |
| China | $1.9 billion | $2.1 billion | 4.3% | -9.7% |
| Switzerland | $1.9 billion | $1.7 billion | 4.2% | 7.1% |
| India | $1.9 billion | $1.8 billion | 4.2% | 3.0% |
| Japan | $1.5 billion | $1.4 billion | 3.3% | 2.4% |
| United Kingdom | $1.3 billion | $1.2 billion | 3.0% | 13.1% |
What the Segment Figures Do Not Show
The rows above add up to 100% of Abbott Laboratories's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.
Where These Numbers Come From
Every figure on this page is a value Abbott Laboratories reported in the segment note and revenue disclosures of its Form 10-K filed February 20, 2026 (accession 0001628280-26-010185), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.
Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.
Frequently Asked Questions
What are Abbott Laboratories's business segments?
In its fiscal 2025 Form 10-K, Abbott Laboratories reports revenue for Medical Devices, Diagnostic Products, Nutritional Products and Established Pharmaceutical Products.
Which part of Abbott Laboratories brings in the most revenue?
Medical Devices, with $21.4 billion of revenue in fiscal 2025, or 48% of the total.
How much of Abbott Laboratories's revenue comes from outside the United States?
61% in fiscal 2025, by the geographic breakdown Abbott Laboratories reports in its Form 10-K. Companies assign revenue to regions differently (customer location, shipping address or selling entity), so check the filing's definition before comparing companies.